(Medical Xpress)—Scientists have identified 46 previously overlooked but potentially 'druggable' cancer targets, using a powerful new online approach that allows researchers to carry out 'virtual experiments' to quickly ...
Jan 2, 2013
0
0
In two publications in Nature Reviews Drug Discovery, Anneliene Jonker (TechMed Center) highlights the importance of health care for rare diseases, and the innovation needed in that. The personalized medicine program manager ...
Oct 25, 2023
0
0
In a recently published article in Nature Reviews Drug Discovery, Professor Yihai Cao's research group at the Department of Microbiology, Tumor and Cell Biology, charts information about drug development for the treatment ...
Apr 14, 2023
0
2
Some diseases are like black swans. They occur so rarely that many physicians never encounter them in their clinical practice, complicating efforts to treat them.
Feb 4, 2020
1
60
Medications currently used to treat multiple sclerosis (MS) can merely reduce relapses during the initial relapsing-remitting phase. Many patients, however, develop progressive MS at a later stage, with disability becoming ...
Aug 20, 2019
0
4
A diagnosis of Alzheimer's disease is devastating for those affected, as there is still no cure for this type of dementia. One hundred years after Alois Alzheimer first described it, we neither have a drug for it, nor do ...
Jun 1, 2018
0
43
The regulatory requirements for the approval of new drugs vary greatly internationally in regards to the resources allocated to the authorities, the evaluation periods for approval and the fees for the pharmaceutical companies. ...
Aug 14, 2017
0
1
Literal heartbreak, from illness or injury, triggers the body's natural healing mechanisms. The result of such mending is often a scar. It's a patch that works, but fibrotic scar tissue replaces healthy heart muscle, a problem ...
Jun 27, 2016
0
1
Lagging behind in launching new medicines means a much smaller market share for pharmaceutical companies—even if they spend just as much on advertising, according to new research from Duke University's Fuqua School of Business.
Sep 4, 2015
0
7
Drug R&D costs have increased substantially in recent decades, while the number of new drugs has remained fairly constant, leading to concerns about the sustainability of drug R&D and question about the factors that could ...
Feb 27, 2015
0
4
